Analyst Alerts: Coca-Cola, IBM, Nxstage Medical, MakeMyTrip April 18th
The Coca-Cola Company (NYSE:KO): Argus raised its price target on Coca-Cola shares to $84 following the company’s better than consensus earnings report. The firm maintains a Buy rating on shares, saying it was particularly encouraged by the company’s volume growth in India and China.
International Business Machines Corp. (NYSE:IBM): Argus attributes IBM’s hardware revenue decline in Q1 to tough comps and IT managers waiting for new servers from Intel. The firm sees strengthening in hardware and overall higher IT spending driving IBM shares to the $220s this year and reiterates a Buy rating on the name. Argus keeps a 12-month price target for shares of $235.
Nxstage Medical, Inc. (NASDAQ:NXTM): JPMorgan recommends buying NxStage on recent weakness and said lackluster Q1 results, expected May 8, are reflected in valuation. The firm expects Q1 patient adds and interim FREEDOM study data around mid-year to drive shares higher. Shares are Overweight rated.
MakeMyTrip Limited (NASDAQ:MMYT): Oppenheimer believes concerns surrounding MakeMyTrip are overblown following reports of inventory withdrawals by two of India’s largest airlines by passenger volumes, Jet Airways and IndiGo. Opco expects MakeMyTrip to resolve the issues in the near-term and said it would be a buyer of MakeMyTrip shares at current levels.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.